The overexpression or over activation of YAP is a common phenomenon in cancers, including non-small cell lung cancer [41], hepatocellular cancer [42], colon cancer [43], gastric cancer [44], and ccRCC [45]. This evidence concerns the gene YAP1 and hepatocellular carcinoma.